Trifluoromethylpyrimidine-based inhibitors of proline-rich tyrosine kinase 2 (PYK2): Structure–activity relationships and strategies for the elimination of reactive metabolite formation

Bibliographic Details
Title: Trifluoromethylpyrimidine-based inhibitors of proline-rich tyrosine kinase 2 (PYK2): Structure–activity relationships and strategies for the elimination of reactive metabolite formation
Authors: Walker, Daniel P., Christopher Bi, F., Kalgutkar, Amit S., Bauman, Jonathan N., Zhao, Sabrina X., Soglia, John R., Aspnes, Gary E., Kung, Daniel W., Klug-McLeod, Jacquelyn, Zawistoski, Michael P., McGlynn, Molly A., Oliver, Robert, Dunn, Matthew, Li, Jian-Cheng, Richter, Daniel T., Cooper, Beth A., Kath, John C., Hulford, Catherine A., Autry, Christopher L., Luzzio, Michael J., Ung, Ethan J., Roberts, W. Gregory, Bonnette, Peter C., Buckbinder, Leonard, Mistry, Anil, Griffor, Matthew C., Han, Seungil, Guzman-Perez, Angel
Source: In Bioorganic & Medicinal Chemistry Letters 1 December 2008 18(23):6071-6077
Database: ScienceDirect
More Details
ISSN:0960894X
DOI:10.1016/j.bmcl.2008.10.030
Published in:Bioorganic & Medicinal Chemistry Letters
Language:English